Transcriptomics reveals new regulatory mechanisms involved in benralizumab response-Reference-Cited by-同舟云学术

Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

Published:2023-08-28 Issue:11 Volume:78 Page:3023-3026
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Estravís Miguel¹²^ORCID,Pérez‐Pazos Jacqueline¹³^ORCID,Moreno‐Jimenez Emma¹⁴^ORCID,Triviño Juan Carlos⁵,García‐Sánchez Asunción¹²⁶^ORCID,Gómez‐García Manuel¹³^ORCID,Morgado Natalia¹⁶^ORCID,Ramos‐González Jacinto⁷,Gil‐Melcón María⁸,Martín‐García Cristina¹⁹^ORCID,Muñoz‐Bellido Francisco¹²⁹^ORCID,Sanz Catalina¹²⁴^ORCID,Isidoro‐García María¹²¹⁰¹¹^ORCID,Dávila Ignacio¹²⁵⁹^ORCID

Affiliation:

1. Instituto de Investigación Biomédica de Salamanca Salamanca Spain

2. Red de Enfermedades Inflamatorias – Instituto de Salud Carlos III Madrid Spain

3. Clinical Biochemistry Department Salamanca, Pharmacogenetics and Precision Medicine Unit Hospital Universitario de Salamanca Salamanca Spain

4. Microbiology and Genetics Department Salamanca Universidad de Salamanca Salamanca Spain

5. Synlab Group Sistemas Genómicos SL Valencia Spain

6. Biomedical and Diagnostics Sciences Department Universidad de Salamanca Salamanca Spain

7. Pneumology Department Hospital Universitario de Salamanca Salamanca Spain

8. Otorhinolaryngology and Head and Neck Surgery Department Hospital Universitario de Salamanca Salamanca Spain

9. Allergy Department Hospital Universitario de Salamanca Salamanca Spain

10. Medicine Department Universidad de Salamanca Salamanca Spain

11. Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain

Funder

Consejería de Educación, Junta de Castilla y León

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15869

Reference6 articles.

1. Identification of whole blood gene expressions correlated with responsiveness to benralizumab

2. Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases

3. PTGDR2 Expression in Peripheral Blood as a Potential Biomarker in Adult Patients with Asthma

4. Gene regulation by long non-coding RNAs and its biological functions

5. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease